CONTACT: Jo Rowbotham, Neogen Corporation, +44 (0) 1706 344 797

ROCHDALE, United Kingdom, 18 March, 2019 — Neogen announced today that Neogen Viroxide Super has been proven effective against the African Swine Fever (ASF) virus at a dilution of 1:800.

Neogen, with continued investment in the efficacy testing of Neogen Viroxide Super, now offers a market-leading, broad spectrum disinfectant and emergency disease control solution worldwide.

ASF is considered one of the most feared diseases for pig producers around the world. It can have a devastating impact on productivity, mortality and severe financial implications for pig farmers. ASF is on the OIE A list of notifiable diseases.

ASF has seen outbreaks during 2018-19 in China, Mongolia, Vietnam, Russia, Ukraine and other parts of Eastern Europe, in addition to Sub-Saharan Africa. The global demand for high quality pork products has resulted in the worldwide movement of pigs and pork products. As there is no current effective treatment for ASF, the need for good biosecurity measures is vital to contain the spread of ASF.

Neogen Viroxide Super offers an effective peroxygen-based disinfectant against ASF at one of the market’s leading dilution rates of 1:800. It is also DEFRA approved for FMD, SVD, and General Orders. The proven, non-resistant, oxidative chemistry causes extensive damage to the protective mechanisms of microbial cells, giving optimum kill of bacteria, viruses, fungi and spores. Neogen Viroxide Super has known chemistry benefits for emergency disease control measures accepted by governments worldwide and should be used as part of an on farm biosecurity strategy.

Neogen Viroxide Super is effective in a wide range of temperatures, in hard water conditions, and in the presence of heavy organic matter. Product applications include disinfection of hard surfaces, equipment, livestock housing, vehicles and foot dips, and aerial fogging and misting applications as part of terminal and continual disinfection programmes.

Neogen Viroxide Super has been developed at Neogen’s facility in Rochdale and manufactured in the United Kingdom. For more information, contact Neogen BioSecurity via e-mail Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein! or visit animalsafety.neogen.com.

Neogen Corporation (NASDAQ: NEOG) develops and markets products dedicated to food and animal safety. The company’s Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen’s Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.


This press release is also available in:  [ PRINTABLE VERSION ] [ PORTUGUESE ] [ SPANISH ]